Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours
- 31 October 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (11) , 1924-1932
- https://doi.org/10.1016/0959-8049(96)00241-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Somatostatin analogue scintigraphy in carcinoid tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- The use of 131I-MIBG in the imaging of metastatic carcinoid tumoursBritish Journal of Cancer, 1988
- The role of I-131-MIBG in the diagnosis and therapy of carcinoidsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1987
- Diagnosis and Treatment of a Carcinoid Tumor Using lodine-131 Meta-iodobenzylguanidineClinical Nuclear Medicine, 1986